[Acute perioperative hemodilution without using hydroxyethyl starch : hemodynamic alterations under "controlled"...

Prior research has shown that hydroxyethyl starch solutions are commonly used to manage volume deficits during acute normovolemic hemodilution. However, regulatory restrictions now limit their use, prompting a reevaluation of alternative fluids like crystalloids. It was already known that crystalloids distribute broadly into extracellular spaces, leading to a high loss rate into interstitial compartments. This gap motivated the investigation of whether crystalloid substitution alone could maintain hemodynamic stability during hemodilution. The 1:5 ratio of crystalloid to blood loss was found to be impractical in maintaining intravascular volume. That uncertainty drove the exploration of a 3:1 substitution ratio as a potential compromise. No prior work had resolved the hemodynamic consequences of moderate hypovolemia under this substitution model. This study aimed to address these unresolved questions in a clinical setting.

The study aimed to evaluate the hemodynamic effects of acute perioperative hemodilution using crystalloids in a 3:1 substitution ratio compared to blood loss. The specific problem addressed was the feasibility of maintaining intravascular volume without hydroxyethyl starch. The motivation stemmed from regulatory changes limiting starch use and the need for alternatives. The researchers sought to determine whether a 3:1 substitution ratio could maintain hemodynamic stability. They also aimed to quantify the volume deficit and assess compensatory mechanisms. The study focused on healthy women undergoing gynecological cancer surgery. The goal was to compare hemodynamic parameters before and after substitution with Ringer's lactate and albumin. The findings could inform clinical practices in fluid management during hemodilution.

The study involved ten healthy women classified as ASA I or II undergoing open gynecological cancer surgery. Blood was withdrawn and replaced with Ringer's lactate in a 3:1 ratio. The volume deficit was measured using a double tracer technique. Hemodynamic changes were assessed using thermodilution and pulse contour analysis via the PiCCO system. After substitution with Ringer's lactate, the remaining deficit was addressed with 20% albumin. Hemodynamic parameters were reevaluated post-infusion. The study compared baseline, post-hemodilution, and post-albumin values. Researchers focused on cardiac output, myocardial contractility, and vascular resistance. The study design allowed for precise quantification of intravascular volume changes.

The substitution of blood loss with Ringer's lactate in a 3:1 ratio led to a 12% decrease in blood volume. The volume effect of Ringer's lactate was 17%, indicating incomplete intravascular retention. Mean arterial pressure and heart rate remained stable throughout the procedure. Cardiac output and myocardial contractility increased significantly during hemodilution. Systemic vascular resistance decreased, suggesting vasodilation. Pulmonary vascular permeability and cardiac preload remained unchanged. Infusion of 245 ml of 20% albumin nearly restored blood volume but did not normalize cardiac output. Systemic vascular resistance increased slightly but not significantly after albumin administration. These findings suggest a compensatory increase in cardiac performance to offset hypovolemia.

The authors propose that intravascular volume loss during hemodilution can be partially compensated by increased cardiac output and contractility. They suggest that this compensatory mechanism may be insufficient in patients with reduced cardiac capacity. The study highlights the hemodynamic changes associated with crystalloid substitution in a 3:1 ratio. The findings indicate that systemic vascular resistance decreases during hypovolemia. Cardiac preload and pulmonary vascular permeability remain stable despite volume loss. The use of albumin partially restores blood volume but does not fully normalize hemodynamic parameters. The authors caution that the effectiveness of this approach may vary in different patient populations. The study supports further investigation into compensatory mechanisms in high-risk patients.